Metro Minnesota Community Oncology Research Consortium (MMCORC) is a clinical research site located in Saint Louis Park, Minnesota, United States 55426.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Metro Minnesota Community Oncology Research Consortium (MMCORC) has participated in 4 clinical trials with 4 currently active.
Therapeutic areas: Uterine Neoplasms, Uterine Cervical Neoplasms, Biliary Tract Neoplasms.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Gilead Sciences, Astellas Pharma Global Development, Inc..
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Metro Minnesota Community Oncology Research Consortium (MMCORC) has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Metro Minnesota Community Oncology Research Consortium (MMCORC) has 4 clinical trials on record, with 4 currently active. Their work covers Uterine Neoplasms, Uterine Cervical Neoplasms, Biliary Tract Neoplasms.
Yes — Metro Minnesota Community Oncology Research Consortium (MMCORC) holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.